Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Open in API
Filings indexed 2,287 across all filing types
Latest filing 2026-05-31 Share Issue/Capital Cha…
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
辽宁成大股份有限公司关于实施回购股份注销暨股份变动的公告
Share Issue/Capital Change Classification · 87% confidence The document is a corporate announcement detailing the completion of a share repurchase cancellation and the corresponding reduction in registered capital and share capital structure. It is not a financial report, AGM materials, management change, or earnings release, but rather a capital change notice. Under the taxonomy, this falls into Share Issue/Capital Change (SHA).
2026-05-31 Chinese
辽宁成大股份有限公司关于召开2025年年度股东会的通知
AGM Information Classification · 88% confidence The document is a formal notice convening the 2025 Annual General Meeting of shareholders of 辽宁成大股份有限公司, detailing the meeting date, voting methods (including network voting), agenda items, attendance and registration procedures, and proxy form. It does not include financial results or call content; rather it is preparatory meeting logistics and materials for an AGM. This matches the definition of AGM Information (AGM-R).
2026-05-25 Chinese
辽宁成大股份有限公司关于公司董事离任的公告
Board/Management Information Classification · 95% confidence The document is an official announcement by the company’s board regarding the resignation of a director (刘志华) and details the departure date, role, and impact on board composition. This matches the category for Board/Management Information announcements.
2026-05-25 Chinese
辽宁成大股份有限公司2025年年度股东会会议文件
AGM Information Classification · 90% confidence The document is titled “2025年年度股东会会议文件” and contains the full agenda, proposals (议案1至议案10), board work report, voting procedures, and other materials intended for the Annual General Meeting. It is clearly meeting materials for an AGM rather than the standalone annual report or proxy statement. Therefore, it should be classified as AGM Information.
2026-05-25 Chinese
辽宁成大股份有限公司关于与专业投资机构共同投资的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a listed company regarding the progress of a co-investment with professional investment institutions into a private fund. It outlines the amounts committed and paid, registration status, and future risk considerations. It is not a full annual/interim report, audit, dividend notice, proxy statement, or management discussion, but rather a disclosure of a financing/investment activity. Therefore it best fits the Capital/Financing Update category (CAP).
2026-05-18 Chinese
辽宁成大股份有限公司关于召开2025年年度暨2026年第一季度业绩暨现金分红说明会的公告
Regulatory Filings Classification · 75% confidence The document is an announcement of a 2025 annual and 2026 Q1 results and cash dividend explanation meeting (an investor briefing), including logistics (time, place, participation instructions). It does not contain actual financial data or the presentation slides themselves, nor is it a transcript. It is a general regulatory announcement that does not fit other specific categories, so it falls under the fallback Regulatory Filings category (RNS).
2026-05-14 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.